DK0603386T3 - Parenteral immunisering mod rotavirus - Google Patents

Parenteral immunisering mod rotavirus

Info

Publication number
DK0603386T3
DK0603386T3 DK93917119T DK93917119T DK0603386T3 DK 0603386 T3 DK0603386 T3 DK 0603386T3 DK 93917119 T DK93917119 T DK 93917119T DK 93917119 T DK93917119 T DK 93917119T DK 0603386 T3 DK0603386 T3 DK 0603386T3
Authority
DK
Denmark
Prior art keywords
rotavirus
immunization against
parenteral immunization
against rotavirus
vaccine
Prior art date
Application number
DK93917119T
Other languages
Danish (da)
English (en)
Inventor
Mary K Estes
Margaret E Conner
Original Assignee
Baylor College Medicine
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25430523&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0603386(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Baylor College Medicine filed Critical Baylor College Medicine
Application granted granted Critical
Publication of DK0603386T3 publication Critical patent/DK0603386T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/15—Reoviridae, e.g. calf diarrhea virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/42—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum viral
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C12N7/04—Inactivation or attenuation; Producing viral sub-units
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/542—Mucosal route oral/gastrointestinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011—Details
    • C12N2720/12011—Reoviridae
    • C12N2720/12311—Rotavirus, e.g. rotavirus A
    • C12N2720/12322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011—Details
    • C12N2720/12011—Reoviridae
    • C12N2720/12311—Rotavirus, e.g. rotavirus A
    • C12N2720/12334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Catalysts (AREA)
  • Medicinal Preparation (AREA)
DK93917119T 1992-07-10 1993-07-12 Parenteral immunisering mod rotavirus DK0603386T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/911,593 US6780630B1 (en) 1992-07-10 1992-07-10 Parenteral immunization against rotavirus
PCT/US1993/006543 WO1994001134A1 (fr) 1992-07-10 1993-07-12 Immunisation parenterale contre des rotavirus

Publications (1)

Publication Number Publication Date
DK0603386T3 true DK0603386T3 (da) 2002-03-11

Family

ID=25430523

Family Applications (1)

Application Number Title Priority Date Filing Date
DK93917119T DK0603386T3 (da) 1992-07-10 1993-07-12 Parenteral immunisering mod rotavirus

Country Status (14)

Country Link
US (1) US6780630B1 (fr)
EP (1) EP0603386B1 (fr)
JP (1) JPH07501558A (fr)
KR (2) KR100354587B1 (fr)
AT (1) ATE211923T1 (fr)
AU (1) AU673370B2 (fr)
CA (1) CA2116971A1 (fr)
DE (1) DE69331459T2 (fr)
DK (1) DK0603386T3 (fr)
ES (1) ES2166763T3 (fr)
IL (1) IL106306A (fr)
NO (1) NO307815B1 (fr)
PT (1) PT603386E (fr)
WO (1) WO1994001134A1 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5626851A (en) * 1987-11-30 1997-05-06 The Wistar Institute Of Anatomy And Biology Rotavirus reassortant vaccine
US6210677B1 (en) * 1993-01-29 2001-04-03 Robert C. Bohannon Method to reduce the physiologic effects of drugs on mammals
US6673355B1 (en) 1995-06-14 2004-01-06 Baylor College Of Medicine Rotavirus enterotoxin NSP4 and methods of using same
EP0833670B1 (fr) * 1995-06-14 2003-09-03 Baylor College Of Medicine Vaccin contre une infection a rotavirus comprenant peptides de l'enterotoxine virale nsp4
CN101835488B (zh) 2007-09-04 2018-10-26 美国政府(由卫生和人类服务部、疾病控制和预防中心的部长所代表) 轮状病毒的热灭活
ES2723776T3 (es) 2009-05-12 2019-09-02 The Government Of The Us Secretary Department Of Health And Human Services Nuevas cepas de rotavirus humano y vacunas
SG11201610921PA (en) * 2014-07-18 2017-02-27 Msd Wellcome Trust Hilleman Lab Pvt Ltd A thermostable freeze dried rotavirus vaccine formulation and process to prepare thereof

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2483779A1 (fr) * 1980-06-05 1981-12-11 Synthelabo Procede pour isoler des antigenes glycoproteiques viraux et son application a la preparation de vaccins
US4341763A (en) * 1981-03-10 1982-07-27 Smithkline-Rit Methods of vaccinating humans against rotavirus infection
US4636385A (en) * 1985-02-15 1987-01-13 The Wistar Institute Of Anatomy & Biology Vaccine, method for its preparation, and use thereof in vaccinating humans against rotavirus infection
US4861864A (en) * 1985-05-14 1989-08-29 Albert Einstein College of Medicine of Yeshiva University (a Div. of Yeshiva University) Rotavirus antigens
US4704275A (en) * 1985-08-26 1987-11-03 The United States Of America As Represented By The Department Of Health And Human Services Vaccine against rotavirus diseases
EP0251467A3 (fr) * 1986-06-20 1988-07-20 Abbott Laboratories Compositions et méthodes de l'utilisation d'une protéine majeure de la capside extérieure (VP7) du rotavirus SA-11
US4927628A (en) * 1987-09-21 1990-05-22 The United States Of America As Represented By The Department Of Health And Human Services Vaccine against rotavirus diseases and method of preparing same
US5147639A (en) * 1990-06-19 1992-09-15 Ambico, Inc. Type-c rotavirus cultures and uses therefor
EP0557427B1 (fr) * 1990-11-16 1998-08-26 Children's Hospital Medical Center Rotavirus humains, vaccins et procedes

Also Published As

Publication number Publication date
EP0603386A4 (en) 1996-05-29
IL106306A (en) 2002-07-25
AU4674093A (en) 1994-01-31
PT603386E (pt) 2002-06-28
IL106306A0 (en) 1993-11-15
KR940702388A (ko) 1994-08-20
JPH07501558A (ja) 1995-02-16
EP0603386B1 (fr) 2002-01-16
NO940827L (no) 1994-05-09
DE69331459T2 (de) 2002-06-20
AU673370B2 (en) 1996-11-07
KR100354587B1 (ko) 2002-10-04
NO307815B1 (no) 2000-06-05
EP0603386A1 (fr) 1994-06-29
ES2166763T3 (es) 2002-05-01
DE69331459D1 (de) 2002-02-21
NO940827D0 (no) 1994-03-09
CA2116971A1 (fr) 1994-01-20
ATE211923T1 (de) 2002-02-15
US6780630B1 (en) 2004-08-24
WO1994001134A1 (fr) 1994-01-20

Similar Documents

Publication Publication Date Title
DK2588D0 (da) Antigen konjugat og fremstilling deraf, samt vaccine indeholdende dette
PL304419A1 (en) Urease based vaccine against heliobacter infections
ATE242319T1 (de) Deletionsmutanten als impfstoffe gegen cholera
AU7814498A (en) Multivalent (in ovo) avian vaccine
ID21338A (id) Metoda untuk menghasilkan kekebalan aktif dengan vaksin gabungan
HUP9701586A2 (hu) Javított inaktivált vakcinák
DK0603386T3 (da) Parenteral immunisering mod rotavirus
DK0536302T3 (da) Forbedrede adjuvanser og vacciner
ATE372129T1 (de) Impfstoff von umhüllten viren und verfahren zu seiner herstellung
Koplan et al. An update on the benefits and costs of measles and rubella immunization.
DK0802796T3 (da) Kyllingeanæmimiddel-slagtekyllingevaccine
PT636030E (pt) Vacina de bacterina-toxoide de pasteurella haemolytica tipo a-1
NO913131L (no) Immunogene konjugater av ikke-toksisk oligosakkarid fra bordetella pertussis lipoolysakkarid.
PT1194450E (pt) Vacina inactivada contra a calicivirose felina
GB9303681D0 (en) Vaccines
AU2579600A (en) Product and method for obtaining specific immunisation with one or more antigens
RU96123912A (ru) Способ иммунопрофилактики экспериментальной лепрозной инфекции
RU2000112250A (ru) Способ сезонной вакцинопрофилактики паротита на крайнем севере
FR2698271B1 (fr) Vaccin contre le virus de la leucémie bovine, nouveau peptide immunogène et kit de vaccination.